Delivery Order SPE2DR25D1053-SPE2DR26FT960
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lynparza 150 mg tablets (120-count units) with a contract ceiling value of $11,136.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lynparza 150 mg tablets (120 count) with a contract value of $10,567.60. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 2, 2025. This delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of LYNPARZA 150 mg tablets in quantities of 60s, with a ceiling value of $10,499.34. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitive, non-set-aside award to the prime contractor. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,249.67 to supply Lynparza 150 mg tablets (60-count units) under a firm fixed-price contract. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-set-aside, competitively awarded procurement. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen Drug Corp's corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Lynparza 150 mg tablets (120 count units) with a ceiling value of $42,270.40. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The order is scheduled for ultimate completion by September 15, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded a $42,270.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units) on August 12, 2025, with an ultimate completion date of September 3, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Lynparza 150 mg tablets (120-count units) with a firm fixed price ceiling value of $21,135.20 and ultimate completion date of September 10, 2025. This delivery order represents a non-competitive award and is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $11,064.68 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of 60 tablets of LYNPARZA 150 mg, with completion scheduled for November 10, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price terms and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of LYNPARZA 150 mg tablets in quantities of 60 units. This contract, valued at $10,499.34, represents a firm fixed-price delivery order with an ultimate completion date of September 22, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order through its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $10,567.60, for the supply of LYNPARZA 150 mg tablets (120-count units) on September 23, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 15, 2025, was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT960Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lynparza 150 mg tablets in a quantity of 60 units, with a contract ceiling value of $11,064.68 and a firm fixed price structure. This delivery order is unclassified as a set-aside contract and represents a competitive award to the pharmaceutical distributor. The place of performance is designated as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a diverse portfolio of medications and medical supplies to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The delivery order for this oncology medication demonstrates the company's role in supplying specialized pharmaceutical products essential to military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 11/17/25 |